One of Ann's strongest beliefs is that we CAN defeat statistics. If a patient is using ONLY conventional therapy, than she or he "fits" the profiles shown in studies on survival.
BUT if that person adds a little something extra/different, they change that category. Many doctors have said they do not KNOW how to assess a patient who has begun using complementary or alternative therapies. Chances are good you have INCREASED your chances for survival.
Boosting the immune system using any of the many ways to do that, adding to your mental strength, living life to the fullest, etc ALL help defeat the statistics.
Go for it!
Below you will find articles, advice, links and anything else we can throw in to help. Also see Questions of Treatment and More, in this section.
June 2004 statement from Musa Mayer, author, advocate:
"While no individual drug has the capacity to extend life more than a few months, we have an increasing portfolio of non-cross-resistant treatments that together do much more when offered in sequence.
There's increasingly convincing data that lives are being extended, in many cases significantly, and without the kind of toxicities you are talking about. In the year 2000, 40% of MD Anderson's metastatic breast cancer patients survived five years or more, as opposed to only 10% in 1975.
I think that number would be somewhat higher today. Virtually every treatment used in metastatic breast cancer has seen FDA approval in the past 12 years, and there are more in the pipeline. Aromatase inhibitors, SERMS and SERDS have made a huge difference to ER or PR+ positive mets patients, who are in the majority.
Does this mean that we should stop fighting for better, less toxic treatments? Or that anything resembling curative treatment is within reach? Of course not...But let's not completely ignore what progress there has been."
The Oncologist, 12/03
Link to a website for patients
with advanced disease
Advanced Breast Cancer: A Guide
to Living with Metastatic Disease
Am J Clinical Oncology, 7/01
9/17/01 Doctor's Guide
on Italian study
Electrolysis of Liver Tumors
Effective Therapy Lacking for Resectable Hepatocellular Ca
Prognostic Factors for Bca w/Liver Mets
J Clin Oncol, 2001
Thanks to Reuters Health
New England J Med, 2001
The Breast, 2/02
Annals of Oncology, 2/02
Annals of Oncology, 1/02
Optimal Duration of CMF-Treatment Failure/Overall Survival
Breast Cancer Research & Treatment
The Breast, 11/02
Survival & Supraclavicular Mets
BR J Cancer, 3/03
Inflammatory Bca/Noninflammatory LABca-Differences
Therapy Sequence No Difference: Inflammatory BCa
The Oncologist, 6/03
Removal of Primary Tumor Helps Metastatic Pts
Screening for Opthalmic Involvement METS BCa
Mets Tumors to the Eye and Orbit
Tumors Metastatic to the (Eye) Orbit
Am J Epidemiology, Oct, 2007
J Integrative Cancer Therapies
Volume 7/Number 9 September 2010 COMMUNITY ONCOLOGY
|Remember we are NOT Doctors and have NO medical training.|
This site is like an Encyclopedia - there are many pages, many links on many topics.
Support our work with any size DONATION - see left side of any page - for how to donate. You can help raise awareness of CAM.